Treatment with the IDO inhibitor INCB024360 increased lysis of human tumor cell targets by peptide-specific CTL
Journal for ImmunoTherapy of Cancer(2015)
Abstract
Meeting abstracts We have investigated the in vitro effects of INCB024360 on dendritic cell maturation and activation of antigen-specific T cells. INCB024360 is a novel inhibitor of indoleamine-2, 3-dioxygenase (IDO), and is currently in several ongoing clinical trials. INCB024360 effectively
MoreTranslated text
Key words
Pancreatic Carcinoma,Prostate Cancer Patient,Human Breast Cancer Cell Line,Kynurenine,Dendritic Cell Maturation
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined